CONFERENCES

      Electronic Nicotine Delivery Systems US Conference

      This is an annual conference that explores the latest developments in electronic nicotine delivery systems (ENDS), with topics ranging from device design to public health policy. The conference is aimed at researchers, industry professionals, and policymakers involved in the study and regulation of ENDS, and provides a forum for sharing knowledge and collaborating on new approaches to reducing tobacco use.

      ENDS US 2019

      Date

      Dec 10, 2019 - Dec 11, 2019

      Location

      Virginia, USA

      This conference includes presentations on the regulatory landscape for ENDS products, the science behind nicotine addiction and harm reduction, the role of ENDS in tobacco harm reduction, and the impact of ENDS use on public health.

      See related presentations

      ENDS US 2018

      Date

      Dec 05, 2018 - Dec 07, 2018

      Location

      Alexandria, USA

      This conference provides attendees with actionable considerations to help navigate the varied approaches and new developments that are influencing the electronic nicotine delivery systems industry.

      See related presentations

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.